NASDAQ:PPD PPD (PPD) Stock Price, News & Analysis → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free PPD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$47.28▼$47.2850-Day Range$47.10▼$47.4152-Week Range$31.54▼$47.41VolumeN/AAverage Volume1.91 million shsMarket Capitalization$16.61 billionP/E Ratio47.28Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get PPD alerts: Email Address Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> About PPD Stock (NASDAQ:PPD)PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.Read More Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> PPD Stock News HeadlinesMarch 28, 2024 | msn.comPPD Made One Mom Fearful of Giving Birth Again, so She Decided on SurrogacyMarch 28, 2024 | msn.comMother killed by Pacifica police after shooting son at apartment complex: authoritiesMarch 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 27, 2024 | msn.comPolice: Searching for 68-year-old endangered adultMarch 27, 2024 | msn.comPlainfield Police Department saves boxer mix, inducts her as gun detection, therapy dogMarch 27, 2024 | dallasnews.comJerry Jones comments on Cowboys QB Dak Prescott lawsuit, sexual assault allegationMarch 27, 2024 | msn.comWomen on Philadelphia police force inspire others looking to follow in their footstepsMarch 27, 2024 | msn.comPPD: Man shot twice while riding bikeMarch 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 27, 2024 | msn.comPPD searching for driver in fatal hit-and-runMarch 26, 2024 | msn.comDriver Shot In Northeast Philadelphia, Say PoliceMarch 26, 2024 | msn.comBaseball: Scoreboard and results for March 20-30March 26, 2024 | msn.comMan arrested in shooting death at Peoria apartment complex, police sayMarch 25, 2024 | finanznachrichten.deLipocine Inc.: Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154March 20, 2024 | msn.comPPD investigating body found near Fountain CreekMarch 20, 2024 | yahoo.comMan wanted for homicide out of Fort Collins arrested in PuebloMarch 19, 2024 | msn.com‘Broadway in Norfolk’ 24-25 season tickets now on saleMarch 18, 2024 | msn.comPineville Police investigating theft on Main StreetMarch 18, 2024 | msn.comThe best deals of Wayfair’s Big Outdoor SaleMarch 18, 2024 | msn.comPowerball, Mega Millions jackpots: Is Virginia ‘due’ for a win?March 18, 2024 | news.yahoo.comThe Mega-Plex wants to bar Providence police from their property. Here's why.March 18, 2024 | msn.comCrash into PPD cruiser investigated as possible DUIMarch 18, 2024 | msn.comNorfolk State Women's Hoops set to play Stanford in opening round of NCAA TournamentMarch 18, 2024 | yahoo.comPPD: Woman injured after shooting in Chestnut StreetMarch 17, 2024 | msn.comMan shot to death in PortsmouthMarch 16, 2024 | news.yahoo.comHartselle man arrested on child pornography chargesMarch 15, 2024 | msn.comStephen Jones says Cowboys met with Dak Prescott about lawsuit, sex assault allegationSee More Headlines Receive PPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PPD and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/27/2021Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:PPD CUSIPN/A CIK1793294 Webwww.ppdi.com Phone910-251-0081FaxN/AEmployees26,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$1.00 Trailing P/E Ratio47.28 Forward P/E Ratio32.16 P/E Growth2.11Net Income$153.69 million Net Margins6.11% Pretax Margin7.31% Return on Equity-89.48% Return on Assets7.94% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$4.68 billion Price / Sales3.55 Cash Flow$1.99 per share Price / Cash Flow23.71 Book Value($1.21) per share Price / Book-39.07Miscellaneous Outstanding Shares351,395,000Free Float344,718,000Market Cap$16.61 billion OptionableNot Optionable Beta1.96 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. David S. Simmons (Age 56)Chairman & CEO Comp: $3.42MMr. Christopher G. Scully (Age 50)Exec. VP, CFO, Treasurer & Assistant Sec. Comp: $1MMr. William J. Sharbaugh (Age 58)Chief Operating Officer Comp: $1.12MMr. Anshul Thakral (Age 43)Exec. VP, Chief Commercial Officer & Pres of Evidera Comp: $1.13MDr. David Michael Johnston (Age 52)Exec. VP of Global Clinical Devel. Comp: $788.87kMr. Glen Donovan (Age 47)Chief Accounting Officer Mr. B. Judd Hartman (Age 57)Exec. VP & Chief Admin. Officer Ms. Tracy H. Krumme (Age 53)VP & Head of Investor Relations Ms. Julia James (Age 46)Exec. VP, Gen. Counsel & Sec. Mr. Ronald E. Garrow (Age 57)Exec. VP & Chief HR Officer More ExecutivesKey CompetitorsCharles River Laboratories InternationalNYSE:CRLIncyteNASDAQ:INCYMedpaceNASDAQ:MEDPPRA Health SciencesNASDAQ:PRAHICON PublicNASDAQ:ICLRView All Competitors Should I Buy PPD Stock? PPD Pros and Cons Explained These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of PPD was last updated on Tuesday, March 26, 2024 at 12:02 AM. Pros Here are some ways that investors could benefit from investing in PPD, Inc.: PPD, Inc. has a strong presence in the biopharmaceutical industry worldwide, offering a wide range of drug development services. David Johnston, Ph.D., the executive vice president and global head of clinical development services at PPD, brings extensive experience and expertise to the company. PPD's Accelerated Enrollment Solutions (AES) business provides data-driven patient recruitment for clinical trials, enhancing study efficiency. Recent collaborations and partnerships, such as the one with Science 37 for digital trials, showcase PPD's commitment to innovation and staying at the forefront of industry trends. Current stock price trends indicate positive momentum and potential growth opportunities for investors. Cons Investors should be bearish about investing in PPD, Inc. for these reasons: Market volatility and regulatory challenges in the biopharmaceutical industry can impact PPD's operations and financial performance. Dependency on external factors, such as government regulations and industry trends, may introduce uncertainties in the company's future prospects. Competition within the drug development services sector is intense, potentially affecting PPD's market share and profitability. Global economic conditions and geopolitical events could influence the demand for PPD's services and impact revenue streams. Investors need to carefully assess the risks associated with investing in a company operating in a highly specialized and regulated industry like biopharmaceuticals. PPD Stock Analysis - Frequently Asked Questions How were PPD's earnings last quarter? PPD, Inc. (NASDAQ:PPD) announced its quarterly earnings data on Wednesday, October, 27th. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.05. The firm had revenue of $1.56 billion for the quarter, compared to analysts' expectations of $1.41 billion. PPD had a negative trailing twelve-month return on equity of 89.48% and a net margin of 6.11%. The company's revenue for the quarter was up 26.5% compared to the same quarter last year. During the same period last year, the firm earned $0.15 earnings per share. What other stocks do shareholders of PPD own? Based on aggregate information from My MarketBeat watchlists, some companies that other PPD investors own include Cisco Systems (CSCO), Alibaba Group (BABA), Johnson & Johnson (JNJ), Salesforce (CRM), Pfizer (PFE), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), RTX (RTX) and Verizon Communications (VZ). When did PPD IPO? PPD (PPD) raised $1.5 billion in an IPO on Thursday, February 6th 2020. The company issued 60,000,000 shares at a price of $24.00-$27.00 per share. Barclays, J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird and William Blair served as the underwriters for the IPO and BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird, William Blair and Drexel Hamilton were co-managers. This page (NASDAQ:PPD) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PPD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.